Brokers Offer Predictions for Lantern Pharma Q2 Earnings
Lantern Pharma Inc. (NASDAQ:LTRN – Free Report) – Equities research analysts at Zacks Small Cap issued their Q2 2025 earnings per share estimates for shares of Lantern Pharma in a research report issued on Monday, May 19th. Zacks Small Cap analyst J. Vandermosten anticipates that the company will earn ($0.53) per share for the quarter. […]
